超越BCMA:神经髓瘤中的新免疫标
Melinda S Y Tan1,2, Yunxin Chen1,2, Eric L Smith3
1Department of Haematology, Singapore General Hospital, Singapore.
Blood advances
|June 12, 2024
概括
针对BCMA以外的新型抗原的新免疫疗法对于在BCMA向治疗后复发的多发性骨髓瘤患者至关重要. 研究探索新的目标和战略,以克服阻力和改善结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 针对B细胞成熟抗原 (BCMA) 的免疫疗法已经改变了多发性骨髓瘤 (MM) 治疗.
- 尽管有效,但大多数患者最终会复发,这凸显了需要新的治疗点的需要.
研究的目的:
- 审查多发性骨髓瘤超出BCMA的新型免疫治疗点.
- 为新兴疗法提供关键的安全性和疗效数据.
- 讨论导航MM免疫疗法不断变化的景观的考虑因素.
主要方法:
- 临床试验和新兴研究的文献综述关于多发性骨髓瘤的新目标.
- 对针对新型抗原的免疫治疗剂的安全性和有效性数据的分析.
- 讨论克服治疗耐药性和优化患者治疗结果的策略.
主要成果:
- 针对BCMA的疗法改善了复发性/耐药性MM的存活率,但长期来说是不够的.
- 目前正在调查GPRC5D,FcRH5和SLAMF7等新型目标.
- 顺序和组合免疫疗法显示出克服抗原损失和改善结果的希望.
结论:
- 开发超越BCMA的新目标对于管理复发性MM至关重要,特别是抗原阴性复发.
- 顺序和组合免疫疗法的战略性使用可能导致无化疗方案.
- 优化治疗时间,T细胞健康以及了解瘤微环境对于最大化治疗效益至关重要.
更多相关视频
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
14.1K
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
12.2K
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:31Hybridoma Technology
14.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.6K
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K